After nearly a decade in the city of Detroit, Genesis Genetics has moved its corporate headquarters to Plymouth.
In the United States, Genesis Genetics focuses its science on two important fertility technologies: Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD), both of which test an embryo for a specific genetic disease it is at risk of inheriting from the parents.
PGD is a laboratory procedure that is used in conjunction with in vitro fertilization (IVF) to help detect certain single-gene diseases. Genesis Genetics was the first to perform this testing and is known globally for the ability to test for some of the rarest genetic conditions.
With PGS, an embryo can be transferred in an IVF cycle after being tested for chromosomal abnormalities. Genesis Genetics’ unique service gives potential parents the ability to quickly decide to undergo the test and select embryos with normal numbers of chromosomes.
In addition to needing more laboratory space for the rapidly growing company, the 13-year-old firm also wanted to move to a location that would be inspirational to its team.
“Our mission is to help couples build healthy families. Plymouth is a quintessential American family town with concerts in the park, a multitude of family festivals, events and parades, and a bustling downtown replete with couples with young families," Tony Gordon, Genesis Genetics Managing Director, said in a news release. "It just made sense.”
Gordon also added that the location is also simpler commute to Detroit Metro Airport as the firm’s work depends on timely courier deliveries.
The biotech company is located in downtown Plymouth, in 705 South Main Street.
“We love that our neighbor to the West, Ann Arbor, has become a mecca for these types of companies, but we are equally thrilled that global companies like Genesis Genetics are thinking about our city and all its offerings,” Mayor Pro-tem, Ed Hingleberg said in the release.
In addition to the headquarters in Plymouth, Genesis Genetics has laboratories in Arizona, Argentina, Brazil, Jordan, South Africa, Taiwan and the United Kingdom.
“The quantity and location of our labs are particularly significant," Gordon said. "It gives us the opportunity to make our tests and customer service available to a global audience.”
For more information, www.genesisgenetics.org.
Source: news release